Eri Kawata

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Alemtuzumab-based HLA-haploidentical transplantation for relapsed/refractory aggressive NK-cell leukemia

Alemtuzumab-based HLA-haploidentical transplantation for relapsed/refractory aggressive NK-cell leukemia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: May 13, 2026

Prognostic impact of KMT2A-PTD in acute myeloid leukemia in the NGS era: a multicenter retrospective study.

Prognostic impact of KMT2A-PTD in acute myeloid leukemia in the NGS era: a multicenter retrospective study.

Journal: Annals of hematology

Published: May 10, 2026

Non-infectious fever defines a subgroup of patients with poorer survival outcomes in high-risk myelodysplastic syndrome.

Non-infectious fever defines a subgroup of patients with poorer survival outcomes in high-risk myelodysplastic syndrome.

Journal: British journal of haematology

Published: February 02, 2026

Lead poisoning diagnosed in a patient with anemia accompanied by abdominal pain

Lead poisoning diagnosed in a patient with anemia accompanied by abdominal pain

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: November 05, 2025

IKZF1 and KRAS Mutated B-cell Acute Lymphoblastic Leukemia with Pseudo-Chédiak-Higashi Granules.

IKZF1 and KRAS Mutated B-cell Acute Lymphoblastic Leukemia with Pseudo-Chédiak-Higashi Granules.

Journal: Internal medicine (Tokyo, Japan)

Published: October 08, 2025

The Emergence of Subclones Following Initial Chemotherapy in Mixed Phenotype Acute Leukemia.

The Emergence of Subclones Following Initial Chemotherapy in Mixed Phenotype Acute Leukemia.

Journal: Cureus

Published: July 02, 2025

Impact of venetoclax trough levels on safety and efficacy in the treatment of acute myeloid leukemia.

Impact of venetoclax trough levels on safety and efficacy in the treatment of acute myeloid leukemia.

Journal: Scientific reports

Published: June 28, 2025

Clinical issues and perspectives in diffuse large B-cell lymphoma based on 15 years of clinical studies by the Kyoto Hematology Clinical Research Group (KOTOSG)

Clinical issues and perspectives in diffuse large B-cell lymphoma based on 15 years of clinical studies by the Kyoto Hematology Clinical Research Group (KOTOSG)

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: April 02, 2025

The real-world efficacy and safety of frontline therapy of obinutuzumab plus bendamustine for untreated high-tumor-burden follicular lymphoma.

The real-world efficacy and safety of frontline therapy of obinutuzumab plus bendamustine for untreated high-tumor-burden follicular lymphoma.

Journal: International journal of clinical oncology

Published: November 24, 2024

A case of renal infiltration by Bence Jones protein kappa-producing lymphoplasmacytic lymphoma.

A case of renal infiltration by Bence Jones protein kappa-producing lymphoplasmacytic lymphoma.

Journal: CEN case reports

Published: November 18, 2024

Associations between Skeletal Muscle Mass, Physical Function, and Quality of Life at Diagnosis in Patients with Hematological Malignancies

Associations between Skeletal Muscle Mass, Physical Function, and Quality of Life at Diagnosis in Patients with Hematological Malignancies

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: January 22, 2024

Prognostic model for relapsed/refractory transplant-ineligible diffuse large B-cell lymphoma utilizing the lymphocyte-to-monocyte ratio.

Prognostic model for relapsed/refractory transplant-ineligible diffuse large B-cell lymphoma utilizing the lymphocyte-to-monocyte ratio.

Journal: International journal of hematology

Published: November 06, 2023

Showing 1-12 of 54

Last Updated: 09/26/2026